AstraZeneca ditches plan to build $558 mln UK vaccine plant (updated)

Astrazeneca Pharma India

31/01/2025 14:16

(Adds AstraZeneca statement)
       LONDON, Jan 31 (Reuters) - AstraZeneca  AZN.L  is no
longer pursuing plans for a 450 million pound ($558.32 million)
vaccine manufacturing plant in Speke, Liverpool, a company
spokesperson said on Friday.
    "Following discussions with the current government, we are
no longer pursuing our planned investment at Speke," an
AstraZeneca spokesperson said in a statement.
        "Several factors have influenced this decision including
the timing and reduction of the final offer compared to the
previous government's proposal.
  
        "The site will continue to produce and supply our flu
vaccine, for patients in the UK and around the world.”
  
($1 = 0.8060 pounds)

 (Reporting by Maggie Fick in London, Yamini Kalia in Bengaluru,
writing by William James; Editing by Kate Holton)
 ((Yamini.Kalia@thomsonreuters.com;))